Atomoxetine for Encopresis in 2 Children With Attention-Deficit/Hyperactivity Disorder

dc.contributor.authorHerguner, Sabri
dc.contributor.authorHerguner, Arzu
dc.date.accessioned2020-03-26T18:24:02Z
dc.date.available2020-03-26T18:24:02Z
dc.date.issued2012
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.doi10.1097/JCP.0b013e3182499abaen_US
dc.identifier.endpage303en_US
dc.identifier.issn0271-0749en_US
dc.identifier.issue2en_US
dc.identifier.pmid22388168en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage302en_US
dc.identifier.urihttps://dx.doi.org/10.1097/JCP.0b013e3182499aba
dc.identifier.urihttps://hdl.handle.net/20.500.12395/27775
dc.identifier.volume32en_US
dc.identifier.wosWOS:000301121100034en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen_US
dc.relation.ispartofJOURNAL OF CLINICAL PSYCHOPHARMACOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleAtomoxetine for Encopresis in 2 Children With Attention-Deficit/Hyperactivity Disorderen_US
dc.typeLetteren_US

Dosyalar